Company intelligence / Profile preview

USV

Mumbai, Maharashtra, Indiausvpeptides.com ↗

Ownership: Private
Development stage: Commercial

Overview

USV is a leading Indian pharmaceutical and biotechnology company with global operations. It manufactures and supplies custom peptides at both research and commercial scale under GMP conditions. The company has three synthetic peptide APIs approved in multiple countries—icatibant, etelcalcetide, and octreotide acetate—and offers custom synthesis services for complex peptides. Its facilities are approved by major regulatory agencies including the US FDA.

Therapeutic areas: EndocrinologyImmunologyNephrology
Modalities: Small moleculePeptidesBiosimilars
Industry: Biotech

Partnerships

Markets Sebamed products in IndiaMarkets Fujix Corp's products outside Japan/US

Beyond the preview

Go deeper on USV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on USV.

Explore the full profile